Market Overview
The Mirna Sequencing And Assay Market covers sequencing platforms, detection assays, reagents, and analysis tools used to study micro ribonucleic acid expression, function, and biomarker relevance across research and translational workflows.Core demand comes from oncology studies, biomarker discovery, translational medicine, liquid biopsy research, academic genomics, and companion diagnostic development, where buyers prioritize reliability, performance, and strong workflow or mission fit. Growth is supported by interest in non invasive biomarkers, growth in precision medicine research, and demand for tools that can support earlier and more targeted disease understanding.
Market Segmentation
By Product
- Sequencing Consumables
- Library Preparation Kits
- Sequencing Platforms / Instruments
- Bioinformatics Pipelines & Services
By Application
- Oncology Diagnostics / Liquid Biopsy
- Drug Discovery & Transcriptome Research
- Other Applications
By Technology
- Sequencing by Synthesis (SBS)
- Ion Semiconductor
- SOLiD
- Nanopore Sequencing
- Single-Molecule Real-Time (SMRT)
By End User
- Clinical Laboratories
- Academic & Research Institutes
- Biotech / Pharma Companies
- Contract Research Organizations
Key Companies Analysed
- Illumina
- Thermo Fisher Scientific
- QIAGEN
- Agilent Technologies
- Takara Bio
- Bio-Rad Laboratories
- PerkinElmer
- Merck KGaA
- New England Biolabs
- Lexogen
- NanoString Technologies
- HTG Molecular Diagnostics
- GenXPro
- Norgen Biotek
- Abcam
- Promega
- OriGene
- LGC Biosearch Technologies
- System Biosciences
- BioVendor
Geographic Coverage
- North America - Market data and outlook to 2034
- United States
- Canada
- Mexico
- Europe - Market data and outlook to 2034
- Germany
- United Kingdom
- France
- Italy
- Spain
- Netherlands
- Switzerland
- Poland
- Sweden
- Russia
- Asia-Pacific - Market data and outlook to 2034
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Malaysia
- Vietnam
- Middle East and Africa - Market data and outlook to 2034
- Saudi Arabia
- South Africa
- Iran
- UAE
- Egypt
- South and Central America - Market data and outlook to 2034
- Brazil
- Argentina
- Chile
- Peru
Report Delivery and Support
- Updated PDF report and an MS Excel workbook containing market tables and figures.
- 7-day post-sale analyst support for clarifications and in-scope supplementary data.
- Complimentary report update covering the latest available data and relevant market developments.
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- Illumina
- Thermo Fisher Scientific
- QIAGEN
- Agilent Technologies
- Takara Bio
- Bio-Rad Laboratories
- PerkinElmer
- Merck KGaA
- New England Biolabs
- Lexogen
- NanoString Technologies
- HTG Molecular Diagnostics
- GenXPro
- Norgen Biotek
- Abcam
- Promega
- OriGene
- LGC Biosearch Technologies
- System Biosciences
- BioVendor
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 160 |
| Published | October 2026 |
| Forecast Period | 2026 - 2034 |
| Estimated Market Value ( USD | $ 413.2 Million |
| Forecasted Market Value ( USD | $ 892.2 Million |
| Compound Annual Growth Rate | 10.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 20 |


